105 related articles for article (PubMed ID: 12739551)
1. FDA aims to improve and streamline the drug development and review process.
Drug News Perspect; 2003; 16(1):40. PubMed ID: 12739551
[No Abstract] [Full Text] [Related]
2. FDA reform: new Senate bill. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Nov; (no 235):7-8. PubMed ID: 11363048
[TBL] [Abstract][Full Text] [Related]
3. New office and new leader aim to streamline FDA cancer drug review process.
Twombly R
J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
[No Abstract] [Full Text] [Related]
4. Drug development research: the process.
Sataloff RT
Ear Nose Throat J; 2008 Aug; 87(8):420-2. PubMed ID: 18712686
[No Abstract] [Full Text] [Related]
5. Food and Drug Administration approval process for ophthalmic drugs in the US.
Lloyd R; Harris J; Wadhwa S; Chambers W
Curr Opin Ophthalmol; 2008 May; 19(3):190-4. PubMed ID: 18408492
[TBL] [Abstract][Full Text] [Related]
6. The process of drug development.
Burgess G
Surviv News (Atlanta Ga); 2002 Mar; ():18. PubMed ID: 11966191
[No Abstract] [Full Text] [Related]
7. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
8. FDA consolidates review process for new pharmaceuticals.
FDA Consum; 2002; 36(6):2. PubMed ID: 12523280
[No Abstract] [Full Text] [Related]
9. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
[TBL] [Abstract][Full Text] [Related]
10. How are drugs approved? Part 3. The stages of drug development.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2008 Mar; 46(3):17-20. PubMed ID: 18416270
[TBL] [Abstract][Full Text] [Related]
11. An FDA perspective on the drug development process.
Woodcock J
Food Drug Law J; 1997; 52(2):145-50. PubMed ID: 10557550
[No Abstract] [Full Text] [Related]
12. FDA issues regulations on accelerated drug-approval process.
Clin Pharm; 1993 Apr; 12(4):253-4. PubMed ID: 8458175
[No Abstract] [Full Text] [Related]
13. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2008; 21(1):36-43. PubMed ID: 18301808
[TBL] [Abstract][Full Text] [Related]
14. FDA revises process for responding to drug applications.
Lang L
Gastroenterology; 2008 Sep; 135(3):721. PubMed ID: 18691586
[No Abstract] [Full Text] [Related]
15. FDA starts moving on critical path, but initiative running out of steam.
Finkelstein JB
J Natl Cancer Inst; 2007 Mar; 99(6):426-7. PubMed ID: 17374831
[No Abstract] [Full Text] [Related]
16. Defending submission-year analyses of new drug approvals.
Carpenter DP
Health Aff (Millwood); 2003; Suppl Web Exclusives():W4-S3-W4-S5. PubMed ID: 15526399
[TBL] [Abstract][Full Text] [Related]
17. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
18. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative.
Cabell CH; Noto TC; Krucoff MW
J Electrocardiol; 2005 Oct; 38(4 Suppl):175-9. PubMed ID: 16226096
[TBL] [Abstract][Full Text] [Related]
20. Drug development: more science, more education.
Aronson JK
Br J Clin Pharmacol; 2005 Apr; 59(4):377-8. PubMed ID: 15801930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
